These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 4355215)
1. Clinical and laboratory investigations on man: systemic administration of potent interferon to man. Strander H; Cantell K; Carlström G; Jakobsson PA J Natl Cancer Inst; 1973 Sep; 51(3):733-42. PubMed ID: 4355215 [No Abstract] [Full Text] [Related]
2. Studies on antiviral and antitumor effects of human leukocyte interferon in vitro and in vivo. Strander H; Cantell K In Vitro Monogr; 1974; (3):49-56. PubMed ID: 4471024 [No Abstract] [Full Text] [Related]
3. Antibody levels to multiple viral antigens in systemic lupus erythematosus and some other connective tissue diseases. Vesikari T; Laitinen O Ann Clin Res; 1974 Aug; 6(4):207-14. PubMed ID: 4372935 [No Abstract] [Full Text] [Related]
4. The effect of a human interferon preparation on vaccine-induced rubella infection. Best JM; Banatvala JE J Biol Stand; 1975; 3(1):107-12. PubMed ID: 1126957 [No Abstract] [Full Text] [Related]
5. Prospects for the medical use of interferon in 1984. Postic B; Arroyo JC Henry Ford Hosp Med J; 1984; 32(2):116-22. PubMed ID: 6210270 [No Abstract] [Full Text] [Related]
6. [Fibroblast-interferon in the treatment of herpes zoster: a pilot study (author's transl)]. Heidemann E; Wilms K; Treuner J; Niethammer D Dtsch Med Wochenschr; 1982 May; 107(18):695-7. PubMed ID: 6176414 [No Abstract] [Full Text] [Related]
7. Administration of human leukocyte interferon in herpes zoster. I. Safety, circulating, antiviral activity, and host responses to infection. Jordan GW; Fried RP; Merigan TC J Infect Dis; 1974 Jul; 130(1):56-62. PubMed ID: 4601181 [No Abstract] [Full Text] [Related]
8. Interferons and interferon inducers: development of clinical usefulness and therapeutic promise. Pollard RB Drugs; 1982; 23(1-2):37-55. PubMed ID: 6173188 [No Abstract] [Full Text] [Related]
9. [Viral etiology of acute pneumonias in children and some of their epidemiological patterns in Kirghizia]. Evdoshenko VG; Kolodin AV; Vorob'eva LM; Pokrovskaia TI; Abdykadyrova DD Vopr Virusol; 1973; 18(6):670-6. PubMed ID: 4364049 [No Abstract] [Full Text] [Related]
10. Physical and immunologic properties of rubella antigens. Schmidt NJ; Lennette EH; Gee PS; Dennis J J Immunol; 1968 Apr; 100(4):851-7. PubMed ID: 5645224 [No Abstract] [Full Text] [Related]
13. [Use of the IgM fraction from patients' sera in general virus serology for diagnostic purposes]. Wolff MH; Marklein G; Schneweis KE; Stifter G Zentralbl Bakteriol Orig A; 1974; 227(1-4):392-400. PubMed ID: 4154618 [No Abstract] [Full Text] [Related]
14. Clinical evaluation of complement-fixation-reaction and hemagglutination-inhibition-test in measles of MS patients. Schorre E Int Arch Allergy Appl Immunol; 1969; 36():Suppl:121-4. PubMed ID: 4313659 [No Abstract] [Full Text] [Related]
15. Detection by immunofluorescence of viral, chlamydial and mycoplasma antigens in men with urethritis. Anghelescu S; Athanasiu P; Petrescu A; Deltin L; Dumitru N; Raica A; Serbănoiu O Virologie; 1985; 36(1):3-10. PubMed ID: 2988192 [TBL] [Abstract][Full Text] [Related]
16. The clinical application of fibroblast interferon--an overview. Billiau A Med Oncol Tumor Pharmacother; 1984; 1(2):87-96. PubMed ID: 6400034 [TBL] [Abstract][Full Text] [Related]
17. Studies on rubella virus. II. Hemagglutination and hemagglutination-inhibition test. Yamane Y; Nagashima T; Takada M; Ikumi H; Owada Y Kitasato Arch Exp Med; 1970 Jun; 43(1):11-21. PubMed ID: 5535193 [No Abstract] [Full Text] [Related]